Skip to content

Aetna Wun Trombley

Chief Executive Officer at Lycia Therapeutics.

Earliest Form D on file: Jun 2026

Filed Jun 25, 2026

Lycia Therapeutics

Extracellular protein degraders for immune diseases

Biotech, South San Francisco CA

Signed as Chief Executive Officer

$75M

sold of $75M offered

Form D

LinkedIn

Network

At Lycia Therapeutics

6 people